Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 41.91
+0.17 (0.41%)
Feb 24, 2026, 1:34 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 13.45 billion as of February 23, 2026. Its market cap has increased by 15.82% in one year.
Market Cap
13.45B
Enterprise Value
11.54B
Revenue
2.72B
Ranking
n/a
PE Ratio
13.73
Stock Price
41.91
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 13.45B, an increase of 829.09%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 13.45B | -1.90% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Medicine | 15.19B |
| Shanghai Haoyuan Chemexpress | 14.95B |
| ApicHope Pharmaceutical Group | 14.95B |
| Beijing Aosaikang Pharmaceutical | 14.49B |
| Shanghai Shyndec Pharmaceutical | 14.26B |
| Guangdong Taienkang Pharmaceutical | 13.52B |
| Zhejiang Jingxin Pharmaceutical | 13.52B |
| Shenzhen Chipscreen Biosciences | 12.98B |